Oncolytics Biotech CEO Matt Coffey to Take Medical Leave of Absence

MT Newswires Live06-24

Oncolytics Biotech (ONCY) said Monday that Chief Executive Officer Matt Coffey will take a medical leave of absence, effective immediately.

Wayne Pisano, chair of Oncolytics' board of directors since 2013, will serve as interim CEO during his absence.

Price: 0.9900, Change: -0.02, Percent Change: -1.98

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment